| Alexander HuppertzAffiliation: Siemens Medical Solutions Country: USA Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observationsAlexander Huppertz Department of Clinical Radiology and Institute of Pathology, Ludwig Maximilians University, Munich, Germany Radiology 234:468-78. 2005 Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approachesWieland H Sommer Department of Clinical Radiology, Munich University Hospitals Großhadern, Marchioninistr 15, 81377, Munich, Germany Abdom Imaging 37:164-79. 2012 Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findingsAlexander Huppertz Institute of Clinical Radiology, Klinikum Grosshadern, University of Munich, Germany Radiology 230:266-75. 2004 Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trialJuha Halavaara Jorvi Hospital, Department of Radiology, Espoo, Finland J Comput Assist Tomogr 30:345-54. 2006 First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumineChristian Klessen Department of Radiology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany Invest Radiol 42:659-64. 2007 Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesionsRenate Hammerstingl Institute of Diagnostic and Interventional Radiology, Johann Wolfgang Goethe University, ZRad, Haus 23 C, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany Eur Radiol 18:457-67. 2008
| |